/RYAN
RYAN Stock - Ryan Specialty Holdings, Inc.
Financial Services|Insurance - SpecialtyNYSE
$52.87-2.38%
$1.29 (-2.38%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.23
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.96
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+25.0%upside
Target: $66.09
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RYAN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$52.34 – $53.40
TARGET (TP)$66.08
STOP LOSS$48.64
RISK/REWARD1:3.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.61
52W High$77.16
52W Low$50.08
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.46B | $2.03B | $1.73B | $1.43B | $1.02B |
| Gross Profit | $944.84M | $728.07M | $1.73B | $488.90M | $358.48M |
| Gross Margin | 38.5% | 35.9% | 100.0% | 34.1% | 35.2% |
| Operating Income | $611.12M | $359.08M | $289.51M | $326.35M | $158.54M |
| Net Income | $94.67M | $61.04M | $61.05M | $65.87M | $68.10M |
| Net Margin | 3.9% | 3.0% | 3.5% | 4.6% | 6.7% |
| EPS | $0.78 | $0.57 | $0.56 | $-0.07 | $0.64 |
Company Overview
Ryan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company was founded in 2010 and is headquartered in Chicago, Illinois.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
9
60%
Hold / Neutral
6
40%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
9 Bullish6 Neutral/Bearish
Price Targets
$62
Average Target
↑ 17.5% Upside
Now
$40
Low
$62
Average
$90
High
Based on 21 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 1st 2025 | Jefferies | Initiation | Hold | $64 |
| November 20th 2025 | Piper Sandler | Initiation | Neutral | $60 |
| September 17th 2025 | Wells Fargo | Upgrade | Overweight | $60 |
| September 16th 2025 | Wolfe Research | Resumed | Outperform | $64 |
| August 13th 2025 | Cantor Fitzgerald | Initiation | Neutral | $61 |
| August 13th 2025 | Citigroup | Initiation | Buy | $74 |
| May 13th 2025 | Goldman | Upgrade | Buy | $81 |
| April 10th 2025 | TD Cowen | Initiation | Buy | $89 |
| December 5th 2024 | Morgan Stanley | Initiation | Overweight | $90 |
| September 24th 2024 | BMO Capital Markets | Upgrade | Outperform | $75← $65 |
| September 5th 2024 | Barclays | Initiation | Overweight | $76 |
| July 11th 2024 | Wells Fargo | Downgrade | Equal Weight | $60← $58 |
| May 22nd 2024 | BofA Securities | Initiation | Buy | $67 |
| May 6th 2024 | Wolfe Research | Downgrade | Peer Perform | - |
| November 20th 2023 | Goldman | Downgrade | Neutral | $53← $57 |
Earnings History & Surprises
RYANBeat Rate
50%
Last 18 quarters
Avg Surprise
+4.7%
EPS vs Estimate
Beats / Misses
9/4
5 met exactly
Latest EPS
$0.47
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.35vs$0.35
Q2 24
+0.1%
$0.35vs$0.35
Q3 24
+3.0%
$0.58vs$0.56
Q4 24
-1.0%
$0.41vs$0.41
Q1 25
-0.2%
$0.45vs$0.45
Q2 25
-0.4%
$0.39vs$0.39
Q3 25
0.0%
$0.66vs$0.66
Q4 25
0.0%
$0.47vs$0.47
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | $0.50 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.47 | $0.47 | 0.0% | = MET |
Q3 2025 | Jul 31, 2025 | $0.66 | $0.66 | 0.0% | = MET |
Q2 2025 | May 1, 2025 | $0.39 | $0.39 | -0.4% | ✗ MISS |
Q1 2025 | Feb 20, 2025 | $0.45 | $0.45 | -0.2% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.41 | $0.41 | -1.0% | ✗ MISS |
Q3 2024 | Aug 1, 2024 | $0.56 | $0.58 | +3.0% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.35 | $0.35 | +0.1% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $0.35 | $0.35 | 0.0% | = MET |
Q4 2023 | Nov 2, 2023 | $0.32 | $0.32 | 0.0% | = MET |
Q3 2023 | Aug 3, 2023 | $0.42 | $0.45 | +7.1% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.25 | $0.26 | +4.0% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $0.27 | $0.27 | 0.0% | = MET |
Q4 2022 | Nov 10, 2022 | $0.26 | $0.25 | -3.8% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $0.36 | $0.39 | +8.3% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $0.21 | $0.24 | +14.3% | ✓ BEAT |
Q1 2022 | Mar 15, 2022 | $0.28 | $0.29 | +3.6% | ✓ BEAT |
Q4 2021 | Nov 11, 2021 | $0.17 | $0.24 | +41.2% | ✓ BEAT |
Q3 2021 | Sep 1, 2021 | $0.32 | $0.35 | +9.4% | ✓ BEAT |
Latest News
Mizuho Initiates Coverage On Ryan Specialty Hldgs with Neutral Rating, Announces Price Target of $61
➖ NeutralBenzinga•Dec 16, 2025, 01:21 PM
Jefferies Initiates Coverage On Ryan Specialty Hldgs with Hold Rating, Announces Price Target of $64
➖ NeutralBenzinga•Dec 1, 2025, 01:12 PM•Also:
TD Cowen Maintains Buy on Ryan Specialty Hldgs, Lowers Price Target to $76
📈 PositiveBenzinga•Nov 26, 2025, 04:21 PM
Piper Sandler Initiates Coverage On Ryan Specialty Hldgs with Neutral Rating, Announces Price Target of $60
➖ NeutralBenzinga•Nov 20, 2025, 05:23 PM
Morgan Stanley Maintains Overweight on Ryan Specialty Hldgs, Raises Price Target to $67
📈 PositiveBenzinga•Nov 17, 2025, 04:38 PM
BMO Capital Maintains Outperform on Ryan Specialty Hldgs, Lowers Price Target to $66
➖ NeutralBenzinga•Nov 3, 2025, 05:43 PM
Keefe, Bruyette & Woods Maintains Outperform on Ryan Specialty Hldgs, Lowers Price Target to $65
📈 PositiveBenzinga•Nov 3, 2025, 04:59 PM
Goldman Sachs Maintains Buy on Ryan Specialty Hldgs, Lowers Price Target to $63
➖ NeutralBenzinga•Nov 3, 2025, 04:33 PM
Ryan Specialty Holdings shares are trading higher after the company reported better-than-expected Q3 sales results.
📈 PositiveBenzinga•Oct 31, 2025, 01:00 PM
Ryan Specialty Holdings shares are trading higher after the company reported better-than-expected Q3 sales results.
📈 PositiveBenzinga•Oct 30, 2025, 08:14 PM
Ryan Specialty Holdings Expects FY25 Organic Revenue Growth Rate Of Double Digits; Adj. EBITDAC Margin Flat To Modestly Down Compared YoY
📈 PositiveBenzinga•Oct 30, 2025, 08:10 PM
Ryan Specialty Hldgs Q3 Adj. EPS $0.47, Inline, Sales $754.577M Beat $737.230M Estimate
📈 PositiveBenzinga•Oct 30, 2025, 08:09 PM
Ryan Specialty Strengthens Canadian Footprint With Planned Acquisition Of Stewart Specialty Risk Underwriting; Deal Terms Not Disclosed
📈 PositiveBenzinga•Oct 28, 2025, 07:51 AM
JP Morgan Maintains Underweight on Ryan Specialty Hldgs, Lowers Price Target to $63
📉 NegativeBenzinga•Oct 9, 2025, 01:50 PM•Also:
Ryan Specialty Holdings Appoints COO Steve Keogh, And CRO Brendan Mulshine To Additional Roles Of Co-Presidents
➖ NeutralBenzinga•Oct 8, 2025, 08:18 PM
UBS Maintains Buy on Ryan Specialty Hldgs, Lowers Price Target to $75
📈 PositiveBenzinga•Oct 8, 2025, 04:27 PM
Wells Fargo Maintains Overweight on Ryan Specialty Hldgs, Raises Price Target to $64
📈 PositiveBenzinga•Oct 8, 2025, 02:09 PM
Morgan Stanley Maintains Overweight on Ryan Specialty Hldgs, Lowers Price Target to $65
➖ NeutralBenzinga•Oct 7, 2025, 03:37 PM
Wells Fargo Upgrades Ryan Specialty Hldgs to Overweight, Maintains Price Target to $60
📈 PositiveBenzinga•Sep 17, 2025, 11:36 AM
Morgan Stanley Maintains Overweight on Ryan Specialty Hldgs, Lowers Price Target to $68
➖ NeutralBenzinga•Aug 18, 2025, 01:47 PM
Frequently Asked Questions about RYAN
What is RYAN's current stock price?
Ryan Specialty Holdings, Inc. (RYAN) is currently trading at $52.87 per share. The stock has moved -2.38% today.
What is the analyst price target for RYAN?
The average analyst price target for RYAN is $66.08, based on 1 analyst.
What sector is Ryan Specialty Holdings, Inc. in?
Ryan Specialty Holdings, Inc. operates in the Financial Services sector, specifically within the Insurance - Specialty industry. The company is traded on the NYSE exchange.
What is RYAN's market cap?
Ryan Specialty Holdings, Inc. has a market capitalization of $6.81 billion, making it a mid-cap company.
Does RYAN pay dividends?
No, Ryan Specialty Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorACGL
Arch Capital Group Ltd.
$96.20
Mkt Cap: $35.8B
ATCO
Atlas Corp.
$15.48
Mkt Cap: $4.5B
BOKF
BOK Financial Corporation
$119.98
Mkt Cap: $7.6B
CADE
Cadence Bank
$43.69
Mkt Cap: $8.1B
ESNT
Essent Group Ltd.
$66.26
Mkt Cap: $6.4B
FAF
First American Financial Corporation
$62.99
Mkt Cap: $6.4B
LNC
Lincoln National Corporation
$46.21
Mkt Cap: $8.8B
MTG
MGIC Investment Corporation
$29.63
Mkt Cap: $6.6B
RNR
RenaissanceRe Holdings Ltd.
$278.52
Mkt Cap: $12.8B
VOYA
Voya Financial, Inc.
$75.29
Mkt Cap: $7.2B
Explore stocks similar to RYAN for comparison